NCT01390922View on ClinicalTrials.gov

Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)

CompletedOBSERVATIONAL

Enrollment

1,038

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Mumps

Interventions

DRUG

Botulinum Toxin Type A

Botulinum Toxin Type A

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01390922 - Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.) | Biotech Hunter | Biotech Hunter